Guangyang Wang
9Patents
3h-index
10Co-inventors
54Inventor score
Filing activity: Jan 24, 1997 → Jan 15, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6649651B1 | Hexahydrofuro[2,3-B]furan-3-yl-n{3[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor | Human Necessities | 9 | Expired |
| US6284163A | Sol-gel encapsulation of lipid vesicles, lipid membranes and proteins | Human Necessities | 4 | Expired |
| US7157495B2 | Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor | Human Necessities | 3 | Expired |
| US6767483B2 | Sol-gel encapsulation of lipid vesicles, lipid membranes and proteins | Human Necessities | 1 | Expired |
| US10381343B2 | Electrostatic protection device of LDMOS silicon controlled structure | Electricity | 0 | Active |
| US11088132B2 | Semiconductor device for enhancing electrostatic discharge protection and layout structure thereof | Electricity | 0 | Active |
| US9343454B2 | Electrostatic discharge protection structure and fabrication method thereof | Electricity | 0 | Active |
| US11264468B2 | Semiconductor device | Electricity | 0 | Active |
| US9780084B2 | Electrostatic discharge protection structure and fabrication method thereof | Electricity | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.